Articles in Business
Everest Re: A Strong Buy - Analyst Blog
4/5/2013, 4:09 pm from Zacks.com in Investing, Business, Stocks
On Apr 4, 2013, Zacks Investment Research upgraded
Everest Re Group Ltd. ( RE ) to a Zacks Rank #1
(Strong Buy). Why the Upgrade? Everest Re has been experiencing rising earnings... Read >>
JinkoSolar to Get $58M Loan - Analyst Blog
4/5/2013, 4:08 pm from Zacks.com in Investing, Business, Stocks
JinkoSolar Holding Co. Ltd. ( JKS ) has entered into
an agreement with China Development Bank for a 15-year loan worth
approximately $58 million (RMB360 million). The loan is backed by
the... Read >>
Flowserve Wins Desalination Contract - Analyst Blog
4/5/2013, 4:08 pm from Zacks.com in Investing, Business, Stocks
Flowserve Corporation ( FLS ) recently won a
multi-million dollar contract from M.N. Larnaca Desalination for
providing a complete pump package and energy recovery devices. The
exact amount... Read >>
Generics: The Way Forward in India? - Analyst Blog
4/5/2013, 4:07 pm from Zacks.com in Investing, Business, Stocks
Earlier this week, the Indian Supreme Court ruled against
Novartis AG ( NVS ) in a patents case
involving its cancer drug Glivec. The impact of the judgment is
seen as far reaching for it... Read >>
GHDX to Show Prostate Test Result - Analyst Blog
4/5/2013, 4:06 pm from Zacks.com in Investing, Business, Stocks
Keeping in line with its strategy to launch its prostate cancer
test by the first half of 2013, Genomic Health,
Inc. ( GHDX ) set a
presentation at the American Urological Association... Read >>
Milestone for Accuray TomoTherapy - Analyst Blog
4/5/2013, 3:09 pm from Zacks.com in Investing, Business, Stocks
Radiosurgery systems maker, Accuray
Incorporated ( ARAY ) announced that
Germany-based Heidelberg University Hospital is the first to use
its latest Tomotherapy technology for patient... Read >>
Glaxo Eyes Benlysta Label Expansion - Analyst Blog
4/5/2013, 3:09 pm from Zacks.com in Investing, Business, Stocks
GlaxoSmithKline ( GSK ) recently
announced that it has initiated a phase III study to evaluate the
use of Benlysta (belimumab) in patients suffering from
anti-neutrophil cytoplasmic... Read >>
QLT Sells PPDS Technology - Analyst Blog
4/5/2013, 3:08 pm from Zacks.com in Investing, Business, Stocks
QLT Inc. ( QLTI ) recently
completed the sale of its punctal plug drug delivery system (PPDS)
technology to Mati Therapeutics Inc. Mati was founded by Robert
Butchofsky, an ex-president and... Read >>
ACE Reiterated at Neutral - Analyst Blog
4/5/2013, 3:08 pm from Zacks.com in Investing, Business, Stocks
We have retained our Neutral recommendation on ACE
Limited ( ACE ). The low interest
rate environment, rising operating expenses and high exposure to
weather related losses will likely... Read >>
Symmetry Reiterated at Neutral - Analyst Blog
4/5/2013, 3:07 pm from Zacks.com in Investing, Business, Stocks
On Apr 3, we retained Symmetry Medical ( SMA ) at Neutral,
following its fourth-quarter results. Although both revenues and
earnings missed estimates, it managed to grow... Read >>